Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease

Treatment has been completed in a Phase 2 clinical trial of brilacidin for ulcerative proctitis and ulcerative proctosigmoiditis — a study that led to six of the 12 patients’ bowel diseases going into remission. Innovation Pharmaceuticals will present the trial results at the Drug Discovery & Therapy World Congress in Boston on July 13. The two
What happened to the phase 3 trial of Brilacidin for staph jnfections or ABBSi. I have information about a patient here in Bend Oregon who is going to die because they have used all of the last resort antibiotics to no effect. If a patient is going to die anyway what would it hurt to treat him with a drug like brilacidin. If it works you have a win win situation.